Literature DB >> 12048246

Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Richard P Visconti1, Charlene D Richardson, Thomas N Sato.   

Abstract

Multiple classes of factors contribute to angiogenesis. In past years, the primary focus has been to understand the functions of individual classes of angiogenic factors. However, few studies have focused on the combinatorial roles of multiple classes of factors in angiogenesis. In this report, we have investigated the in vivo angiogenic processes regulated by two major classes of angiogenic factors, the angiopoietins and vascular endothelial growth factor (VEGF). Here we show that angiopoietin-1, a factor previously considered to be proangiogenic, can offset VEGF-induced angiogenesis in vivo. We also provide direct in vivo evidence for the synergistic effect of angiopoietin-2 and VEGF on the induction of angiogenesis. Furthermore, we show that these two classes of factors control the ratio of arterial and venous blood vessel types during angiogenesis. We believe that our study is a step toward understanding how multiple classes of factors harmonize angiogenesis and blood vessel types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048246      PMCID: PMC123048          DOI: 10.1073/pnas.122109599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Authors:  P C Maisonpierre; C Suri; P F Jones; S Bartunkova; S J Wiegand; C Radziejewski; D Compton; J McClain; T H Aldrich; N Papadopoulos; T J Daly; S Davis; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

2.  A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis.

Authors:  F Shalaby; J Ho; W L Stanford; K D Fischer; A C Schuh; L Schwartz; A Bernstein; J Rossant
Journal:  Cell       Date:  1997-06-13       Impact factor: 41.582

3.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

Authors:  G Thurston; C Suri; K Smith; J McClain; T N Sato; G D Yancopoulos; D M McDonald
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

4.  Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

Authors:  S Davis; T H Aldrich; P F Jones; A Acheson; D L Compton; V Jain; T E Ryan; J Bruno; C Radziejewski; P C Maisonpierre; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Authors:  C Suri; P F Jones; S Patan; S Bartunkova; P C Maisonpierre; S Davis; T N Sato; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

Review 6.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

7.  Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice.

Authors:  T M Schlaeger; S Bartunkova; J A Lawitts; G Teichmann; W Risau; U Deutsch; T N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Increased vascularization in mice overexpressing angiopoietin-1.

Authors:  C Suri; J McClain; G Thurston; D M McDonald; H Zhou; E H Oldmixon; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  Vascular endothelial cell lineage-specific promoter in transgenic mice.

Authors:  T M Schlaeger; Y Qin; Y Fujiwara; J Magram; T N Sato
Journal:  Development       Date:  1995-04       Impact factor: 6.868

View more
  84 in total

Review 1.  Emerging concept in angiogenesis: specification of arterial and venous endothelial cells.

Authors:  Thomas N Sato
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 2.  Fishing for novel angiogenic therapies.

Authors:  Kameha R Kidd; Brant M Weinstein
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 3.  Emerging techniques to treat corneal neovascularisation.

Authors:  J Menzel-Severing
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

4.  Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Authors:  Ketan B Ghaghada; Cristian T Badea; Lohitash Karumbaiah; Nicole Fettig; Ravi V Bellamkonda; G A Johnson; Ananth Annapragada
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

Review 5.  Epicardial-myocardial signaling directing coronary vasculogenesis.

Authors:  Harold E Olivey; Eric C Svensson
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

6.  Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Kristin E Hubert; Michael R Powers
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

Review 7.  Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature.

Authors:  Kory J Lavine; David M Ornitz
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

8.  Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea.

Authors:  Zhi-Xin Yan; Yi Luo; Ning-Fei Liu
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.

Authors:  Yung Hae Kim; Huiqing Hu; Salvador Guevara-Gallardo; Michael T Y Lam; Shun-Yin Fong; Rong A Wang
Journal:  Development       Date:  2008-11       Impact factor: 6.868

10.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.